<DOC>
	<DOCNO>NCT01079975</DOCNO>
	<brief_summary>This observational , non control , multicentric , prospective study plan conduct 350 subject diagnose multiple sclerosis ( MS ) 20 centre Argentina identify predictive factor lead depression . The incidence depression symptom influence evolution disease unknown Argentinean population . Early diagnosis depression symptom allow specific treatment also delay rich apparition disease . This study intend quantify incidence symptom also aim evaluate predictive factor apparition depression .</brief_summary>
	<brief_title>To Identify Evaluate Predictive Factors Depression Patients Diagnosed With Multiple Sclerosis</brief_title>
	<detailed_description>Multiple sclerosis chronic , demyelinate disease central nervous system consider one common cause neurological disability young adult . The clinical pathophysiological characteristic disease lead association several condition time , among depression and/or depression symptoms one important one . The underlie mechanism depression clear etiology depression consider multifactorial especially associate psychosocial stress , presence focal demyelinating lesion immune malfunction . Several scale like Beck Depression Inventory Fast Screen ( BDI FS ) , Mini Mental State Examination ( MMSE ) , Hamilton Depression Rating Scale ( HDRS ) use objectify presence depression symptom subject MS . OBJECTIVES Primary objective : - Identification predictive factor development depression symptom subject MS Argentina Secondary objective : - Evaluation proportion subject develop depression symptom follow The subject manage clinical therapeutic element treat doctor consider appropriate , without modify decision due subject ' inclusion study .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Subjects age 18 65 year sexes Subjects establish MS diagnosis accord revise Mc Donald criterion 2005 clinical form Subjects sign informed consent Subjects wiling follow study procedure Subjects diagnosis depression moment initial evaluation Subjects receive antidepressant drug moment initial evaluation Subjects moderate severe cognitive impairment Antecedents psychiatric disease Subjects receive receive experimental treatment 6 month inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Multiple sclerosis</keyword>
	<keyword>Depression</keyword>
</DOC>